California's late summer COVID surge is showing signs of peaking, but the state's war with the Trump administration over vaccines is just beginning.
22 hours ago
0
0
Scientists have developed a smarter way to activate the immune system against cancer, potentially making treatments safer and more precise.
Sep 16, 2025
0
2
When air conditioning is not available during extreme heat, millions of older adults and other people become vulnerable to cardiac problems and other heat-related illnesses, according to researchers in the Penn State Department ...
Sep 16, 2025
0
0
It starts with a sneeze. Someone on the subway didn't cover their mouth and now a cloud of invisible invaders hangs in the air. Before you even step off the train, your immune system has already begun fighting off the threat ...
Sep 16, 2025
0
1
For anyone unfortunate enough to have grown up without them, tomatillos might seem tough to approach. They hide inside a papery cloak and tend to hang out in the quietest corners of produce sections in the U.S.—if they ...
Sep 16, 2025
0
1
When Spencer Gibson arrived at the University of Alberta four years ago to assume his new role as the Dianne and Irving Kipnes Endowed Chair in Lymphatic Disorders in the Faculty of Medicine & Dentistry, he knew the task ...
Sep 16, 2025
0
0
Research from Edith Cowan University (ECU) has revealed that both resistance training and high intensity interval training (HIIT) produced sufficient levels of myokines to help in the fight against cancer.
Sep 16, 2025
0
0
Novel research shows that in approximately one third of countries and territories worldwide, population aging was the largest contributor to the growing burden of musculoskeletal disorders from 1990 to 2021.
Sep 16, 2025
0
0
Health Secretary Robert F. Kennedy Jr.'s new vaccine advisory committee meets this week, with votes expected on whether to change recommendations on shots against COVID-19, hepatitis B and chickenpox.
Sep 16, 2025
0
0
From Bambino Gesù Children's Hospital in Rome comes a report that a third-generation CAR T cell therapy targeting GD2, designated GD2–CART01, induced durable remissions and long-term survival in children with high-risk ...
